Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Modulation of cytokeratin subtype, EGF receptor, and androgen receptor expression during progression of prostate cancer.

Human pathology - 1 Sept 1998

Gil-Diez de Medina S, Salomon L, Colombel M, Abbou C C, Bellot J, Thiery J P, Radvanyi F, Van der Kwast T H, Chopin D K

Abstract excerpt

After initial regression in response to androgen deprivation, most prostate cancers develop resistance to endocrine therapy. Identification of cellular and molecular changes occurring during endocrine therapy-induced regression and subsequent hormone insensitivity may point to mechanisms underlying the transition to hormone-independent prostate cancer. A series of untreated (n = 24), regressed (n = 15), and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to EGF gene

Share to Immunoenzyme Techniques

Share to Keratins

Share to Phenotype

Share to Polymerase Chain Reaction

Share to RNA, Messenger

Source

Identifiers

PMID: 9744319
DOI: 10.1016/s0046-8177(98)90208-8

Genes

EGF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Modulation of cytokeratin subtype, EGF receptor, and androgen receptor expression during progression of prostate cancer.PMID 9744319Read ↗

Molecular mechanisms in hormone-resistant prostate cancer.Semantic proximity Read ↗

[Hormone-resistant epithelial cancer of the prostate].Semantic proximity Read ↗

Androgen receptor signaling in androgen-refractory prostate cancer.Semantic proximity Read ↗

Signaling Pathways That Control Apoptosis in Prostate CancerSemantic proximity Read ↗

Androgen receptor gene amplification and protein expression in hormone refractory prostate cancerSemantic proximity Read ↗

Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells.Semantic proximity Read ↗

Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.Semantic proximity Read ↗

EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance.Semantic proximity Read ↗

Gene amplification and mutation analysis of epidermal growth factor receptor in hormone refractory prostate cancer.Semantic proximity Read ↗

Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells.Semantic proximity Read ↗

Pattern of somatic androgen receptor gene mutations in patients with hormone-refractory prostate cancer.Semantic proximity Read ↗

N-(4-hydroxyphenyl)retinamide (4-HPR) decreases neoplastic properties of human prostate cells: an agent for prevention.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.